|
| Status |
Public on Jan 03, 2016 |
| Title |
Luteolin_Treated_Test_10um_2 |
| Sample type |
RNA |
| |
|
| Source name |
Luteolin_Treated_Test_10um
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: HNSCC cell line Cal27
agent: Luteolin
dose: 10um
|
| Treatment protocol |
Cal27 cells were treated with luteolin with DMSO as control for 24 hours
|
| Growth protocol |
Cal27 cells were grown in standard culture conditions
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Trizol method
|
| Label |
Cy3
|
| Label protocol |
Agilent mRNA Complete Labeling and Hybridization Kit
|
| |
|
| Hybridization protocol |
As per manufacturer recommended protocol
|
| Scan protocol |
As per manufacturer recommended protocol
|
| Data processing |
Raw data analyzed by GeneSpring Gx v 12.0
gProcessed Signal was normalized to 50th Percentile and median to all samples using GeneSpring GX v 12.0
|
| |
|
| Submission date |
Nov 16, 2015 |
| Last update date |
Apr 23, 2018 |
| Contact name |
madavan vasudevan |
| E-mail(s) |
madavan.vasudevan@gmail.com
|
| Phone |
+91-9845093355
|
| Organization name |
Theomics International Private Limited
|
| Street address |
Kasturi Nagar
|
| City |
Bangalore |
| State/province |
Karnataka |
| ZIP/Postal code |
560043 |
| Country |
India |
| |
|
| Platform ID |
GPL16699 |
| Series (1) |
| GSE75029 |
Inhibition of p300 Lysine Acetyltransferase activity by Luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model [mRNA] |
|
| Relations |
| Reanalyzed by |
GSE113533 |
